Pulse Biosciences CS (PLSE) Stock Price, Quote & News

Company Profile

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment c...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 510-906-4600

Website: www.pulsebiosciences.com

Address:

601 Brickell Key Drive, Suite 1080, Miami, United States

AlertsAndNews Apr. 25 at 9:00 PM

$PLSE some Saturday data PR Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026 "Key study findings on the 5 second ablation cohort include: Sustained 100% procedural success of evaluable patients by holter at 6 months (95/95) Sustained 96% procedural success of evaluable patients by holter at one year (51/53) Sustained 90% Kaplan-Meier estimate of freedom from AF/AFL/AT at one year"

0 · Reply

prismmarketview Apr. 24 at 2:04 PM

$PLSE PFA is already reshaping AF ablation (projected $3B+ global PFA market). Pulse Biosciences is betting its nsPFA can be more precise and tissue‑selective than thermal RF/cryo. https://prismmarketview.com/nanosecond-pulses-billion-dollar-market-pulse-biosciences-nspfa-tech-takes-aim-at-afib-heavyweights/

0 · Reply

TruthBroker2 Apr. 23 at 1:38 PM

$SMMT $PLSE

0 · Reply

Carl81 Apr. 22 at 2:59 PM

$PLSE $SMMT

0 · Reply

TruthBroker2 Apr. 22 at 12:15 PM

$ABBV $SMMT $PLSE

0 · Reply

Orbit100 Apr. 21 at 3:25 PM

$PLSE Hold on for the analysts event on April 25th.

0 · Reply

TruthBroker2 Apr. 21 at 2:21 PM

$SMMT $PLSE

0 · Reply

bob2013 Apr. 21 at 12:19 PM

$PLSE Sweet home Chicago, Marriott hotel April 25 (HE KNOWS)!!!

0 · Reply

TruthBroker2 Apr. 21 at 2:26 AM

$PLSE

0 · Reply

BIOTECH_GURU Apr. 20 at 10:47 PM

$PLSE not bullish enough. I see this above $100 in 12 months.

1 · Reply

Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026

Apr 20, 2026, 7:00 AM EDT - 5 days ago

Pulse Biosciences' nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting

Apr 17, 2026, 7:00 AM EDT - 8 days ago

Pulse Biosciences to Host Analyst Event on April 25, 2026

Apr 16, 2026, 9:30 AM EDT - 9 days ago

Pulse Biosciences Transcript: 25th Annual Needham Virtual Healthcare Conference

Apr 9, 2026, 7:00 AM EDT - 16 days ago

Pulse Biosciences Strengthens Executive Leadership Team

Apr 7, 2026, 7:00 AM EDT - 18 days ago

Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation

Apr 2, 2026, 4:05 PM EDT - 23 days ago

Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference

Mar 18, 2026, 10:40 AM EDT - 5 weeks ago

Pulse Biosciences Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Mar 17, 2026, 7:00 AM EDT - 5 weeks ago

Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data

Mar 12, 2026, 7:00 AM EDT - 6 weeks ago

Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology

Mar 9, 2026, 7:00 AM EDT - 6 weeks ago

Pulse Biosciences Announces Clinical Data From nPulse™ Vybrance™ System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation

Mar 5, 2026, 7:00 AM EST - 7 weeks ago

Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Mar 4, 2026, 1:10 PM EST - 7 weeks ago

Pulse Biosciences Transcript: TD Cowen 46th Annual Health Care Conference

Mar 4, 2026, 7:00 AM EST - 7 weeks ago

Pulse Biosciences' nPulse™ Vybrance™ System to be Featured in Multiple Presentations at the North American Society for Interventional Thyroidology Meeting

Feb 20, 2026, 4:05 PM EST - 2 months ago

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feb 20, 2026, 7:00 AM EST - 2 months ago

Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference

Feb 19, 2026, 4:30 PM EST - 2 months ago

Pulse Biosciences Earnings Call Transcript: Q4 2025

Feb 19, 2026, 4:05 PM EST - 2 months ago

Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results

Feb 9, 2026, 9:18 AM EST - 2 months ago

What's Going With Pulse Biosciences Stock On Monday?

Feb 5, 2026, 7:00 PM EST - 2 months ago

Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium

Feb 4, 2026, 4:05 PM EST - 2 months ago

Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026

Feb 3, 2026, 7:00 AM EST - 2 months ago

Pulse Biosciences' nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium

Jan 14, 2026, 6:45 PM EST - 3 months ago

Pulse Biosciences Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 9, 2026, 7:00 AM EST - 3 months ago

Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors

Jan 6, 2026, 7:00 AM EST - 3 months ago

Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium

Dec 29, 2025, 4:05 PM EST - 4 months ago

Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 18, 2025, 7:00 AM EST - 4 months ago

Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation

Dec 9, 2025, 7:00 AM EST - 4 months ago

Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse™ Technology

Dec 3, 2025, 9:50 AM EST - 5 months ago

Pulse Biosciences Transcript: Piper Sandler 37th Annual Healthcare Conference

Nov 13, 2025, 2:40 PM EST - 5 months ago

Pulse Biosciences Transcript: Stifel 2025 Healthcare Conference

Nov 6, 2025, 4:05 PM EST - 6 months ago

Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences

Nov 5, 2025, 4:30 PM EST - 6 months ago

Pulse Biosciences Earnings Call Transcript: Q3 2025

Nov 5, 2025, 4:05 PM EST - 6 months ago

Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results

Oct 24, 2025, 7:00 AM EDT - 6 months ago

Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study

Oct 22, 2025, 4:05 PM EDT - 6 months ago

Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025

Oct 10, 2025, 7:00 AM EDT - 7 months ago

Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting

Oct 7, 2025, 7:00 AM EDT - 7 months ago

Pulse Biosciences Announces Clinical Data Highlighting its nPulse™ Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting

Sep 10, 2025, 7:00 AM EDT - 8 months ago

Pulse Biosciences' nPulse™ Technology to be Featured at the American Thyroid Association 2025 Annual Meeting

Sep 8, 2025, 7:00 AM EDT - 8 months ago

Pulse Biosciences Announces FDA IDE Approval to Initiate its nsPFA Cardiac Surgery System Study for the Treatment of Atrial Fibrillation

Sep 2, 2025, 7:00 AM EDT - 8 months ago

Pulse Biosciences Announces First Successful Procedures in PRECISE Benign Thyroid Nodule (BTN) Study

Aug 26, 2025, 7:00 AM EDT - 8 months ago

Pulse Biosciences Announces Publication of First-In-Human Data for Treatment of Benign Thyroid Nodules in the Journal Thyroid

Aug 13, 2025, 11:00 AM EDT - 9 months ago

Pulse Biosciences Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Aug 12, 2025, 4:30 PM EDT - 9 months ago

Pulse Biosciences Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:05 PM EDT - 9 months ago

Pulse Biosciences Reports Business Updates and Second Quarter 2025 Financial Results

Aug 1, 2025, 7:00 AM EDT - 9 months ago

Pulse Biosciences To Present at the 45th Canaccord Genuity Annual Growth Conference

Jul 29, 2025, 4:05 PM EDT - 9 months ago

Pulse Biosciences Schedules Second Quarter 2025 Business Updates and Financial Results Conference Call for August 12, 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Pulse Biosciences Earnings Call Transcript: Q1 2025

May 8, 2025, 4:05 PM EDT - 1 year ago

Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results

May 6, 2025, 4:05 PM EDT - 1 year ago

Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference

May 1, 2025, 7:00 AM EDT - 1 year ago

Pulse Biosciences' Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting

Apr 24, 2025, 4:05 PM EDT - 1 year ago

Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025

Apr 23, 2025, 7:00 AM EDT - 1 year ago

Pulse Biosciences' Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting

Apr 10, 2025, 9:30 AM EDT - 1 year ago

Pulse Biosciences Transcript: 24th Annual Needham Virtual Healthcare Conference

Mar 27, 2025, 4:30 PM EDT - 1 year ago

Pulse Biosciences Earnings Call Transcript: Q4 2024

Mar 27, 2025, 4:05 PM EDT - 1 year ago

Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results

Mar 26, 2025, 4:05 PM EDT - 1 year ago

Pulse Biosciences To Present at the 24th Annual Needham Virtual Health Care Conference

Mar 7, 2025, 8:00 AM EST - 1 year ago

Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025

Mar 5, 2025, 10:30 AM EST - 1 year ago

Pulse Biosciences Transcript: TD Cowen 45th Annual Healthcare Conference

Feb 20, 2025, 4:05 PM EST - 1 year ago

Pulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference

Feb 4, 2025, 8:00 AM EST - 1 year ago

Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer

Jan 30, 2025, 8:00 AM EST - 1 year ago

Pulse Biosciences' Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting

Jan 21, 2025, 7:00 AM EST - 1 year ago

Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium

Jan 13, 2025, 6:00 PM EST - 1 year ago

Pulse Biosciences Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 13, 2025, 7:00 AM EST - 1 year ago

Pulse Biosciences' Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium

Jan 10, 2025, 8:00 AM EST - 1 year ago

Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer

Oct 30, 2024, 4:30 PM EDT - 1 year ago

Pulse Biosciences Earnings Call Transcript: Q3 2024

Aug 14, 2024, 8:00 AM EDT - 1 year ago

Pulse Biosciences Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024

Aug 12, 2024, 4:30 PM EDT - 1 year ago

Pulse Biosciences Earnings Call Transcript: Q2 2024

May 7, 2024, 4:30 PM EDT - 2 years ago

Pulse Biosciences Earnings Call Transcript: Q1 2024

Mar 28, 2024, 4:30 PM EDT - 2 years ago

Pulse Biosciences Earnings Call Transcript: Q4 2023

Nov 29, 2023, 8:10 AM EST - 2 years ago

Pulse Biosciences Transcript: Piper Sandler 35th Annual Healthcare Conference

Nov 13, 2023, 12:00 PM EST - 2 years ago

Pulse Biosciences Earnings Call Transcript: Q3 2023

Aug 10, 2023, 4:30 PM EDT - 2 years ago

Pulse Biosciences Earnings Call Transcript: Q2 2023

May 11, 2023, 4:30 PM EDT - 3 years ago

Pulse Biosciences Earnings Call Transcript: Q1 2023

Mar 30, 2023, 4:30 PM EDT - 3 years ago

Pulse Biosciences Earnings Call Transcript: Q4 2022

Nov 10, 2022, 2:00 PM EST - 3 years ago

Pulse Biosciences Earnings Call Transcript: Q3 2022

Aug 10, 2022, 4:30 PM EDT - 4 years ago

Pulse Biosciences Earnings Call Transcript: Q2 2022

AlertsAndNews Apr. 25 at 9:00 PM

0 · Reply

prismmarketview Apr. 24 at 2:04 PM

0 · Reply

TruthBroker2 Apr. 23 at 1:38 PM

$SMMT $PLSE

0 · Reply

Carl81 Apr. 22 at 2:59 PM

$PLSE $SMMT

0 · Reply

TruthBroker2 Apr. 22 at 12:15 PM

$ABBV $SMMT $PLSE

0 · Reply

Orbit100 Apr. 21 at 3:25 PM

$PLSE Hold on for the analysts event on April 25th.

0 · Reply

TruthBroker2 Apr. 21 at 2:21 PM

$SMMT $PLSE

0 · Reply

bob2013 Apr. 21 at 12:19 PM

$PLSE Sweet home Chicago, Marriott hotel April 25 (HE KNOWS)!!!

0 · Reply

TruthBroker2 Apr. 21 at 2:26 AM

$PLSE

0 · Reply

BIOTECH_GURU Apr. 20 at 10:47 PM

$PLSE not bullish enough. I see this above $100 in 12 months.

1 · Reply

Orbit100 Apr. 20 at 7:12 PM

$PLSE LSEG has Pulse at the Strong Buy with the target price of $30!

0 · Reply

TruthBroker2 Apr. 20 at 3:22 PM

$SMMT $PLSE Im Feelin a afternoon Run

0 · Reply

TruthBroker2 Apr. 20 at 6:32 AM

$PLSE $SMMT

0 · Reply

Stocks_and_Stacks Apr. 19 at 1:20 PM

🚀 Bulls dominating Friday April 17 as Strait of Hormuz reopens and oil crashes 9-11%! 🐂📈 First off ….who’s all up late studying charts and getting ready for next week? Our group just received two new banger alerts that have serious 100-200% run potential. Eyes sharp, bulls! Huge congrats to everyone riding these top 5 movers today $MAAS +32% – Maase Inc surging on high volume and speculative momentum. $CRML +35% – Critical Metals climbing amid broader materials sector strength and positive sentiment. $PLSE +14% – Pulse Biosciences lifting on biotech interest and healthcare rotation. $ELVR +13% – Elevra Lithium gaining on commodity tailwinds as oil drop eases input costs. $CAR + momentum extension – Avis Budget Group extending strong April run on travel demand and small-cap rally. Epic week stacking wins with new record highs, bulls. 💪 Who else is celebrating big gains today? Drop your winners below. #TopMovers #BullMarket #Stocks #BangerAlerts #StraitOpen

0 · Reply

TruthBroker2 Apr. 18 at 3:20 PM

$PLSE

0 · Reply

topstockalerts Apr. 17 at 10:05 PM

$PLSE this strength feels real… not just a quick pop

0 · Reply

Orbit100 Apr. 17 at 7:35 PM

$PLSE Got in Pulse at $17.80 by 5,000 shares based on its catheter technology. A great potential of partership to Abbott, Medtronic, Johnson Johnson, Boston. Build this position up for a future buyout. A rare gem to get in low now.

0 · Reply

TruthBroker2 Apr. 17 at 5:19 PM

$SMMT $PLSE

0 · Reply